Corporate News     20-Oct-21 Board of Jagsonpal Pharmaceuticals recommends interim dividend Of Rs.4 per share Jagsonpal Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 19 October 2021, inter alia, have recommended the interim dividend of Rs.4 per equity share(i.e.80%), subject to the approval of the shareholders. Previous News   Jagsonpal Pharmaceuticals standalone net profit rises 53.41% in the September 2024 quarter  ( Results - Announcements 24-Oct-24   07:29 )   Jagsonpal Pharmaceuticals to declare Quarterly Results  ( Corporate News - 28-Oct-25   11:12 )   Jagsonpal Pharmaceuticals allots 11,575 equity shares under ESOP  ( Corporate News - 13-Mar-25   18:58 )   Jagsonpal Pharmaceuticals allots 1.09 lakh equity shares under ESOP  ( Corporate News - 06-Jan-26   20:17 )   Jagsonpal Pharmaceuticals standalone net profit declines 99.41% in the March 2022 quarter  ( Results - Announcements 31-May-22   08:13 )   Jagsonpal Pharmaceuticals to conduct board meeting  ( Corporate News - 16-May-23   15:29 )   Board of Jagsonpal Pharmaceuticals recommends final dividend  ( Corporate News - 24-May-23   15:01 )   Jagsonpal Pharmaceuticals standalone net profit rises 82.29% in the September 2021 quarter  ( Results - Announcements 20-Oct-21   07:42 )   Jagsonpal Pharmaceuticals announces board meeting date  ( Corporate News - 05-Aug-22   13:44 )   Jagsonpal Pharmaceuticals Ltd leads gainers in 'B' group  ( Hot Pursuit - 01-Jun-21   12:15 )   Jagsonpal Pharmaceuticals to hold board meeting  ( Corporate News - 04-Nov-22   15:21 )	Other Stories   IDFC First Bank allots 20.16 lakh equity shares under ESOS   12-Mar-26   19:29   ICICI Lombard General Insurance Company allots 91,272 equity shares under ESOS   12-Mar-26   19:27   AU Small Finance Bank allots 1.33 lakh equity shares under ESOP   12-Mar-26   19:21   Bikaji Foods International allots 1.43 lakh equity shares under ESOS   12-Mar-26   19:19   Ideaforge Technology allots 756 equity shares under ESOP   12-Mar-26   19:17   Board of Max Financial Services approves QIP issue of Rs 2,000 cr   12-Mar-26   19:13   WeWork receives ratings action from CRISIL   12-Mar-26   19:10   Sigma Advanced System exits non-core pharma investment   12-Mar-26   19:06   AURUM sells buildings worth Rs 112 cr to fund its AI-led PropTech platforms   12-Mar-26   19:00   Board of Jagsonpal Pharmaceuticals approves shares buyback of Rs 40 cr   12-Mar-26   18:55
Back Top